Le Duc, however, paints a different picture of the WIV. “I have visited and toured the new BSL4 laboratory in Wuhan, prior to it starting operations in 2017- … It is of comparable quality and safety measures as any currently in operation in the US or Europe.”
BUT
https://www.sciencedirect.com/science/article/pii/S2588933819300391
However, the maintenance cost is generally neglected; several high-level BSLs have insufficient operational funds for routine yet vital processes. Due to the limited resources, some BSL-3 laboratories run on extremely minimal operational costs or in some cases none at all.12
this is a lot of word salad about chinese labs
3.2. Inadequate biosafety management systems
Since the promulgation and implementation of “Regulations on Biosafety Management of Pathogenic Microorganism Laboratories,” issued by State Council in 2004, a series of other regulations have been formulated by different ministries and local governments. These have considered the examination and approval of laboratory construction and accreditation, authorization of research activities, as well as pathogen, waste, and laboratory animal management regulations. Although these regulations wholesomely cover all aspects of construction, management, and eventual operation of BSLs, their enforcement still needs to be strengthened. Furthermore, due to different investment sources, affiliations, and management systems, the implementation of these laboratories faces difficulties converging objectives and cooperation workflows. This scenario puts laboratory biosafety at risk since the implementation efficiency and timely operations are relatively compromised.